About this trial
In this study we will test the effect of local intraureteric aminophylline instillation through Ureteric stent and Reaching stone without the need of ballon dilataion
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
The study will include patients with failed stone accessibility by semi-rigid ureteroscopy.
Disqualifiers
Child age group
Pre stented patients
Contraindications to aminophylline (hypersensitivity to drug components, pregnancy or lactation ,…)
Contraindications to ureteroscopy (active urinary tract infection - Contraindications to general or spinal anesthesia - Uncorrected bleeding disorders)
Trial design
Sequential
Treatments tested in this trial
ureteral dilatation
Procedure/SurgeryDirect semi-rigid ureteroscopy will initially be attempted without endodilatation (KARL STORZ, 43 cm, 6°, 7 Fr.). On failure to advance the semi-rigid ureteroscope through the ureter, intra-ureteric instillation of 20 ml of aminophylline (250 mg/10 mL) through ureteric stent and another trial to pass the same scope will be done after 10 minutes of intra-ureteral aminophylline instillation.
Treatment groups
Trial outcomes
Primary outcomes
Success rate of Ureteral access and Scoping of the stones after Intra-ureteral instillation of Aminophylline without Ballon Dilatation
Success rate of Ureteral access and Scoping of the stones after Intra-ureteral instillation of Aminophylline without Ballon Dilatation
Secondary outcomes
Success of complete extraction of stones
Success of complete extraction of stones after intraureteric injection of aminophylline
Sponsors and contacts
Click on the lead sponsor to view all of their trials.